Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Hovens

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Journal of Case Reports in Internal Medicine|February 14, 2019
Severe Acquired Coagulopathy During Fulminant <i>Staphylococcus aureus</i> Sepsis Most Likely Caused by <i>S. aureus</i> Exotoxins (SSLs)Lonneke Draaijers, Robert-Jan Hassing, Menno Kooistra, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2025
Absorption of apixaban following metabolic bariatric surgery: is reluctance still warranted?Claudia Berends, Cedric Lau, Laura Heusschen, et al.
Obesity Surgery|November 25, 2021
Anti-Xa Levels in Morbidly Obese Patients Using Apixaban or Rivaroxaban, Before and After Bariatric SurgeryThom Kok, Hans de Boer, Bart Witteman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitorNeeltje Steeghs, Hans Gelderblom, Jos Op 't Roodt, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Journal of Case Reports in Internal Medicine|February 14, 2019
Severe Acquired Coagulopathy During Fulminant <i>Staphylococcus aureus</i> Sepsis Most Likely Caused by <i>S. aureus</i> Exotoxins (SSLs)Lonneke Draaijers, Robert-Jan Hassing, Menno Kooistra, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2025
Absorption of apixaban following metabolic bariatric surgery: is reluctance still warranted?Claudia Berends, Cedric Lau, Laura Heusschen, et al.
Obesity Surgery|November 25, 2021
Anti-Xa Levels in Morbidly Obese Patients Using Apixaban or Rivaroxaban, Before and After Bariatric SurgeryThom Kok, Hans de Boer, Bart Witteman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitorNeeltje Steeghs, Hans Gelderblom, Jos Op 't Roodt, et al.
Pageof 1